MR Imaging of Benign and Malignant Pleural Disease

Magnetic Resonance Imaging Clinics of North America

Volumn 16, Issue 2, 2008, Pages 319-339

  Gill, Ritu R ^a   Gerbaudo, Victor H ^a   Jacobson, Francine L ^a   Trotman Dickenson, Beatrice ^a   Matsuoka, Shin ^a   Hunsaker, Andetta ^a   Sugarbaker, David J ^a   Hatabu, Hiroto ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Mesothelioma; MR; Pleura; Pleural malignancy; Pleural plaques; Pleural thickening

Indexed keywords

GADOLINIUM;

ANATOMY; BENIGN TUMOR; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HEMATOMA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIPOMA; LIPOSARCOMA; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEURA CAVITY; PLEURA DISEASE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA MESOTHELIOMA; PLEURA METASTASIS; PLEURA PLAQUE; PLEURA THICKENING; PLEURA TUMOR; POSITRON EMISSION TOMOGRAPHY; REVIEW; SOLITARY FIBROUS TUMOR; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING;

HUMANS; MAGNETIC RESONANCE IMAGING; PLEURAL DISEASES; PLEURAL NEOPLASMS;

EID: 43049160843     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2008.03.004     Document Type: Review

References (48)

1. Leung A., Muller N.L., and Miller R.R. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 154 3 (1990) 487-492
2. McLoud T.C. CT and MR in pleural disease. Clin Chest Med 19 2 (1998) 261-276
3. Wilson A.G. Pleura and pleural disorders. In: Armstrong P., Wilson A.G., Dee P., et al. (Eds). Imaging of diseases of the chest (1995), Mosby, London 641-716
4. Maskell N.A., and Butlan R.J. BTS guidelines for the investigation a unilateral pleural effusion in adults. Thorax 58 Suppl 2 (2003) ii8-ii17
5. Davis S.D., Henschke C.I., Yankelevitz D.F., et al. MR imaging of pleural effusions. J Comput Assist Tomogr 14 2 (1990) 192-198
6. Baysal T., Bulut T., Gokimak M., et al. Diffusion weighted MR imaging of pleural fluid; differentiation of transudative vs exudative pleural effusions. Eur Radiol 14 5 (2004) 890-896
7. Qureshi N.R., and Geeson F.V. Imaging of pleural disease. Clin Chest Med 27 2 (2006) 193-213
8. Hahn P.F., Stark D.D., Vici L.G., et al. Duodenal hematoma: the ring sign in MR imaging. Radiology 159 2 (1986) 379-382
9. McLoud T.C., and Flower C.D. Imaging the pleura: sonography, CT and MR imaging. AJR Am J Roentgenol 156 (1991) 1145-1153
10. Rockoff S.D., Kagan E., Schwartz A., et al. Visceral pleural thickening in asbestos exposure: the occurrence and implications of thickened interlobar fissures. J Thorac Imaging 2 4 (1987) 58-66
11. Proto A.V. Conventional chest radiographs: anatomic understanding of newer observations. Radiology 183 (1992) 593-603
12. Weber M.A., Bock M., Plathow C., et al. Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques. Invest Radiol 39 9 (2004) 554-564
13. Theros E.G., and Feigin D.S. Pleural tumors and pulmonary tumors: differential diagnosis. Semin Roentgenol 12 (1977) 239-247
14. Rosado-de-Christenson M.L., Abbott G.F., McAdams H.P., et al. Localized fibrous tumor of the pleura. Archives of the AFIP. Radiographics 23 (2003) 759-783
15. Tateishi U., Nishihara H., Morikawa T., et al. Solitary fibrous tumor of the pleura: MR appearance and enhancement pattern. J Comput Assist Tomogr 26 2 (2002) 174-179
16. Williford M.E., Hidalgo H., Putman C.E., et al. Computed tomography of pleural disease. AJR Am J Roentgenol 140 5 (1983) 909-914
17. Davies C., and Gleeson F.V. Diagnostic radiology. In: Light R.W., and Lee Y.C. (Eds). Textbook of pleural diseases (2003), Arnold, London 210-237
18. Sung M.S., Kang H.S., Suh J.S., et al. Myxoid liposarcoma appearance at MR imaging with histologic correlation. Radiographics 20 4 (2000) 1007-1019
19. Lynch D.A., Gamsu G., Ray C.S., et al. Asbestos related focal lung masses; manifestations on conventional and high resolution CT scans. Radiology 169 (1988) 603-607
20. Copley S.J., Wells A.J., Rueben M.B., et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 220 1 (2001) 237-243
21. McHugh K., and Blaquiere R.M. CT features of round atelectasis. AJR Am J Roentgenol 153 (1989) 257-260
22. Henschke C.I., Yankelevitz D.F., and Davis S.D. Pleural diseases: multimodality imaging and clinical management. Curr Probl Diagn Radiol 20 (1991) 155-181
23. Shuman L.S., and Libshitz H.I. Solid pleural manifestations of lymphoma. AJR Am J Roentgenol 142 (1984) 269-273
24. Hierholzer J., Lou L., Bittner R.C., et al. MRI and CT in the differential diagnosis of malignant from benign pleural disease. Clin Med J (Engl) 114 (2001) 645-649
25. Falaschi F., Battola L., Zampa V., et al. Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases. Radiol Med (Torino) 92 (1996) 713-718
26. Patz E.F., Shaffer K., Piwnica-Worms D.R., et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 159 5 (1992) 961-966
27. Kramer H., Pieteman R.M., Slebos D.J., et al. PET for the evaluation of pleural thickening observed on CT. J Nucl Med 45 (2004) 995-998
28. Duysinx B., Nguyen D., Louis R., et al. Evaluation of pleural disease with 18-flourodeoxyglucose positron emission tomography imaging. Chest 125 (2004) 489-493
29. Yamamuro M., Gerbaudo V.H., Gill R.R., et al. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 64 3 (2007) 356-366 [Epub Oct 22, 2007]
30. Corson J.M. Pathology of mesothelioma. Thorac Surg Clin 14 4 (2004) 447-460
31. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108 4 (1995) 1122-1128
32. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 1 (1999) 54-63
33. Kawashima A., and Libshitz H.I. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 155 5 (1990) 965-969
34. Metintas M., Ucgun I., Elbek O., et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol 41 1 (2002) 1-9
35. Drevs J., and Schneider V. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumor agents targeting angiogenesis. J Intern Med 260 6 (2006) 517-529
36. Giesel F.L., Bischoff H., von Tengg-Kobligk H., et al. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome. Chest 129 6 (2006) 1570-1576
37. Heelan R.T., Rusch V.W., Begg C.B., et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 172 4 (1999) 1039-1047
38. Zucali P.A., and Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer 42 16 (2006) 2706-2714
39. Wang Z.J., Reddy G.P., Gotway M.B., et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 24 1 (2004) 105-119
40. Plathow C., Klopp M., Fink C., et al. Quantitative analysis of lung and tumour mobility: comparison of two time-resolved MRI sequences. Br J Radiol 78 (2005) 836-840
41. Brix G., Semmler W., Port R., et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15 4 (1991) 621-628
42. Hatabu H., Gaa J., Kim D., et al. Pulmonary perfusion: quantitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and invasion recovery turbo FLASH. Magn Reson Med 36 (1996) 503-508
43. Ohno Y., Hatabu H., Takenaka D., et al. Solitary pulmonary nodules; potential role of dynamic MR imaging in management-initial experience. Radiology 224 (2002) 503-511
44. Bénard F., Sterman D., Smith R.J., et al. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 114 3 (1998) 713-722
45. Erasmus J.J., Truong M.T., Smythe W.R., et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications. J Thorac Cardiovasc Surg 129 6 (2005) 1364-1370
46. 18F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 43 (2002) 1144-1149
47. Gerbaudo V.H., Britz-Cunningham S., Sugarbaker D.J., et al. Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma. Thorax 58 12 (2003) 1077-1082
48. Gerbaudo V.H. 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero.... Nucl Med Commun 24 6 (2003) 609-614